Hvis det er nødvendigt at skifte mellem de to formuleringer, anbefales det at gøre det under klinisk supervision i tilfælde af toleranceproblemer (se afsnit 5. 2).
It is recommended that if a switch of formulations is required this is done under clinical supervision, in case of problems with tolerability (see section 5.2).